Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

baby-784607_960_720

Mallinckrodt gets two thumbs down from FDA for jaundice drug

May 4, 2018 Medical Communications, Sales and Marketing InfaCare, Mallinckrodt, biotech, drugs, pharma, pharmaceutical

Mallinckrodt paid $80 million, with a further $345 million dependent on milestones, to acquire InfaCare in the hope that the …
News
webinar

Free webinar – Rational EU risk management for oncology medicines

May 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA Group, biotech, drugs, pharma, pharmaceutical

It is timely to reflect on how we can best implement the revised GVP module (V) concerning risk management in …
News
bms

BMS looks to leverage real-world data, with Flatiron collab

May 3, 2018 Medical Communications, Sales and Marketing Bristol-Myers Squibb, Flatiron health, biotech, drugs, pharma, pharmaceutical

Bristol-Myers Squibb has extended its existing collaboration with Flatiron Health by three years and expanded the efforts both will be …
News
sugar_tax

The UK sugar tax: A sweet or sour move?

May 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, obesity, pharma, sugar tax

Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …
Feature

Sandoz US woes continue with biosimilar rejection

May 3, 2018 Sales and Marketing Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – …
News
20170628182643b6d1090b2-8235-4860-8281-743f52e15ed4

Samsung BioLogics’ shares down $6bn after accounting furore

May 2, 2018 Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …
News
novartis_window

Novartis becomes first to gain second CAR T indication

May 2, 2018 Research and Development, Sales and Marketing Gilead, Kymriah, Novartis, Yescarta, biotech, drugs, pharma, pharmaceutical

Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …
News
praluentalirocumab_1211441

Sanofi/Regeneron forced to slash price in wake of slow sales

May 1, 2018 Research and Development, Sales and Marketing Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical, praluent

Sanofi and Regeneron were touted as having a sure-fire blockbuster on their hands when they first brought Praluent to market …
News
jon_neal-1_0

Takeda announces new UK MD, ahead of Shire transformation

May 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Takeda, appointment, pharma

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …
Appointment
credit_rich_s

United Therapeutics to acquire SteadyMed for $216 million

May 1, 2018 Manufacturing and Production, Sales and Marketing SteadyMed, UnitedTherapeutics, acquisition, pharma

United Therapeutics is set to acquire speciality pharma firm SteadyMed after it emerged that the pair had signed a definitive …
News
medopad

Connecting patients to doctors

April 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …
Feature

EMA’s CHMP backs Roche’s Perjeta combo in HER2-positive breast cancer

April 30, 2018 Sales and Marketing Cancer, Herceptin, Perjeta, Roche, breast cancer, pharma

Roche’s Perjeta has edged one step closer to approval as a combo therapy after the EMA’s Committee for Medicinal Products …
News
piggy-2889042_960_720

Alzheon shies away from $81m IPO

April 30, 2018 Sales and Marketing Alzheon, biotech, drugs, pharma, pharmaceutical

Alzheon, a tiny biotech based in the Boston area, had initially launched its roadshow for an IPO potentially worth up …
News
allergan

Allergan unveils second bout of Phase 3 success in migraine

April 30, 2018 Research and Development, Sales and Marketing Allergan, migraine, pharma, ubrogepant

Allergan has revealed new data from the second of two Phase 3 studies into the efficacy of its calcitonin gene-related …
News
canada_and_usa_flag

US applies pressure on Canada to stem cross-border generics flow

April 30, 2018 Sales and Marketing Canada, IP, US, biotech, drugs, pharma, pharmaceutical

The US has upped the ante against Canada to secure stronger border checks for pharmaceutical goods by adding the country …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025